fifty-one patients with metastatic breast cancer were randomly allocated to receive either a four drug combination consisting of cyclophosphamide , methotrexate , 5-fluorouracil , and prednisone ( cmfp ) , or a combination of vincristine , adriamycin , and cyclophosphamide ( vac ) with cross-over on relapse .
C0055985
cmfp
C0010583
vac